Aimmune Therapeutics

Aimmune Therapeutics is a biotechnology company focused on developing treatments for Food Allergies. Their main product, Palforzia, is an oral immunotherapy designed to reduce the severity of peanut allergy reactions. It works by gradually exposing patients to small, increasing amounts of peanut protein to build tolerance over time. This approach aims to improve safety and quality of life for individuals with severe food allergies, reducing the risk of accidental, potentially life-threatening reactions. Aimmune’s work represents an important step toward more effective management of food allergies through personalized, targeted therapies.